Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.
Press releases published on July 22, 2025

Hepsiburada to Announce Second Quarter 2025 Results on July 31, 2025
ISTANBUL, July 22, 2025 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services …

Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025
ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …

Atico Mining Announces Closing of Rights Offering
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) is …

Ellomay Capital Announces the Acquisition of 15% of Dorad Energy’s Shares by Ellomay Luzon Energy, Increasing Ellomay Luzon Energy’s Holdings in Dorad to 33.75%
Tel-Aviv, Israel, July 22, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, the USA and Israel, …

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
CANTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Pharvaris Announces Proposed Public Offering of Ordinary Shares
ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated …

Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will …

$10b for saving lives: global Aussie firm backs big, bold fund for world wide rescues
A critical global need for funds for natural disaster response is on track to be realised with the radical $10b Project Rescue Disaster Relief Unification Fund. BRISBANE, QUEENSLAND, AUSTRALIA, July 22, 2025 /EINPresswire.com/ -- A critical global need …

Alexander Johnson Group Partners with GEMS School of Research and Innovation to Support for Families Moving to Dubai
DUBAI, UNITED ARAB EMIRATES, July 22, 2025 /EINPresswire.com/ -- Alexander Johnson Group, a premier provider of a private banking-like approach to commercial and luxury real estate in Dubai, has proudly announced its partnership with GEMS School of …

ESET has strengthened its position in the 2025 Gartner® Magic Quadrant™ for Endpoint Protection Platforms
DUBAI , DUBAI, UNITED ARAB EMIRATES, July 22, 2025 /EINPresswire.com/ -- ESET, a global leader in cybersecurity, proudly announces that it is one of only two vendors, out of fifteen evaluated, to improve its relative position in the 2025 Gartner® Magic …

LATRO Deepens Commitment to African Telecommunications Market with New Office Opening in Liberia
LATRO’s ambitious global growth strategy and its unwavering commitment to fostering growth across Africa with the newest regional office in Monrovia, Liberia MONROVIA, LIBERIA, July 22, 2025 /EINPresswire.com/ -- LATRO, a global leader in …

Century Aluminum Company Closes Private Offering of $400 Million of Senior Secured Notes
CHICAGO, July 22, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) (“Century”) announced today that it closed its private offering of 6.875% senior secured notes due August 2032 (the “Secured Notes”) for gross proceeds of $400 million. The …

Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy
LA PALMA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today announced that it has initiated a strategic …

Dubai Chambers to Unveil Investment Opportunities at Inaugural Dubai Business Forum – USA in New York
DUBAI, United Arab Emirates, July 22, 2025 (GLOBE NEWSWIRE) -- Dubai Chambers today announced its inaugural Dubai Business Forum – USA will take place in New York City at Cipriani South on November 12th. The forum will provide detailed insight into the …

HT Vet Survey Reveals HT Vista’s Ability to Increase ROI for Veterinary Clinics
HILLSIDE, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- HT Vet, the veterinary health technology company behind HT Vista, the only non-invasive, first-line cancer detection tool for dogs, today announced survey results showing that veterinary practices using the …

Octup Raises $12M Seed Round to Build the Operating System for 3PLs
TEL AVIV, Israel, July 22, 2025 (GLOBE NEWSWIRE) -- Octup, the real-time AI operations platform for third-party logistics providers (3PLs), today announced it has closed $12 million Seed round co-led by Shine Capital and JAL Ventures, with participation …

Outlook Therapeutics Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
Video webcast now available on-demand ISELIN, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, …

GRI Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
– Video webcast now available on-demand LA JOLLA, CA, July 22, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the …

Palisade Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
– Video webcast now available on-demand Carlsbad, CA, July 22, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel …

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study
Ra’anana, Israel, July 22, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced encouraging preclinical results supporting the …